Project probing whether high-impact papers can be replicated releases latest results

Nature will publish more details on experiments described in life-sciences papers.

A few years back, scientists at the biotechnology company Amgen set out to replicate 53 landmark studies that argued for new approaches to treat cancers using both existing and new molecules. They were able to replicate the findings of the original research only 11 percent of the time.

Containerization technology takes the hassle out of setting up software and can boost the reproducibility of data-driven research.

A team of researchers suggest that the increasing complexity of managing data may be one reason that reproducibility has fallen off.

Contribution to the public debate on the “replication crisis” / “Replicability essentially touches on the quality of research and concerns all of science”.

Contaminated samples, faulty studies and inadequate training have created a crisis in laboratories and industry, slowing the quest for new treatments and cures.

U.S. taxpayers pay $30 billion a year to fund biomedical research aimed at finding better treatments. But competition for scarce funding and tenure may be prompting some scientists to cut corners.

PLOS now partners directly with protocols.io to provide authors better ways to share methodological details about their work, practical tools to reduce wasted research efforts and persistent, citable identifiers for laboratory methods.

eLife now accepting manuscripts in R Markdow at innovation@elifesciences.org.

Funnel plots are a popular tool in spotting when scientists in a field leave out negative study results, but one researcher says the method is flawed.

Efforts to get to grips with the problem have meant new ideas and technologies are now being brought to bear

Dr. Carlo Croce was repeatedly cleared by OhioState University, which reaped millions from hisgrants. Now, he faces new whistle-blower accusations.